Literature DB >> 3377811

5'-Deoxy-5'-methylthioadenosine: a nucleoside which differentiates between adenosine receptor types.

R Munshi1, A S Clanachan, H P Baer.   

Abstract

The activities of an endogenous nucleoside, 5'-deoxy-5'-methylthioadenosine (MTA), on adenosine sensitive sites such as adenosine A1 and A2 receptors and the P-site, as well as on purine nucleoside transport, have been studied. This nucleoside competitively antagonized the A2 receptor-mediated stimulation of neuroblastoma adenylate cyclase, produced a GTP-dependent and 8-p-sulfophenyltheophylline-sensitive inhibition of adenylate cyclase activity in rat cerebellar membranes, and decreased the spontaneous contractile activity of isolated segments of rabbit jejunum. MTA was neither active at the P-site nor did it diminish the binding of [3H]nitrobenzylthioinosine, a nucleoside transport inhibitor. We conclude that (a) MTA is an agonist at the adenosine A1 receptor but an antagonist at the A2 receptor, and (b) the adenosine receptor which causes relaxation of rabbit jejunum is not a neuroblastoma-type A2 receptor which activates adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3377811     DOI: 10.1016/0006-2952(88)90560-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  S-Adenosylmethionine regulates connexins sub-types expressed by hepatocytes.

Authors:  Sachie Yamaji; Anna Droggiti; Shelly C Lu; Maria L Martinez-Chantar; Anne Warner; Marta Varela-Rey
Journal:  Eur J Cell Biol       Date:  2010-11-18       Impact factor: 4.492

2.  A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis.

Authors:  Jeffrey H Mills; Do-Geun Kim; Antje Krenz; Jiang-Fan Chen; Margaret S Bynoe
Journal:  J Immunol       Date:  2012-04-23       Impact factor: 5.422

3.  EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.

Authors:  Ayse Batova; Howard Cottam; John Yu; Mitchell B Diccianni; Carlos J Carrera; Alice L Yu
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

4.  9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.

Authors:  Guangchun Han; Guoliang Yang; Dapeng Hao; Yang Lu; Kyaw Thein; Benjamin S Simpson; Jianfeng Chen; Ryan Sun; Omar Alhalabi; Ruiping Wang; Minghao Dang; Enyu Dai; Shaojun Zhang; Fengqi Nie; Shuangtao Zhao; Charles Guo; Ameer Hamza; Bogdan Czerniak; Chao Cheng; Arlene Siefker-Radtke; Krishna Bhat; Andrew Futreal; Guang Peng; Jennifer Wargo; Weiyi Peng; Humam Kadara; Jaffer Ajani; Charles Swanton; Kevin Litchfield; Jordi Rodon Ahnert; Jianjun Gao; Linghua Wang
Journal:  Nat Commun       Date:  2021-09-23       Impact factor: 17.694

5.  Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice.

Authors:  M Ujue Latasa; Carmen Gil-Puig; Maite G Fernández-Barrena; Carlos M Rodríguez-Ortigosa; Jesús M Banales; Raquel Urtasun; Saioa Goñi; Miriam Méndez; Sara Arcelus; Nerea Juanarena; Juan A Recio; Sophie Lotersztajn; Jesús Prieto; Carmen Berasain; Fernando J Corrales; Jon Lecanda; Matías A Avila
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

Review 6.  The Role of Amino Acids in Endothelial Biology and Function.

Authors:  Meng Li; Yanqing Wu; Lei Ye
Journal:  Cells       Date:  2022-04-18       Impact factor: 7.666

7.  Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.

Authors:  K A Jacobson; S M Siddiqi; M E Olah; X D Ji; N Melman; K Bellamkonda; Y Meshulam; G L Stiles; H O Kim
Journal:  J Med Chem       Date:  1995-05-12       Impact factor: 7.446

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.